Can a common antibiotic beat syphilis?
NCT ID NCT05548426
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether the antibiotic linezolid can effectively treat early syphilis in 24 adults. Participants have primary, secondary, or early latent syphilis, and some also have well-controlled HIV. The main goal is to see if linezolid reduces syphilis infection markers in the blood within 6 months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYPHILIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Howard Brown Health
Chicago, Illinois, 60613, United States
-
Open Arms HealthCare Center
Jackson, Mississippi, 39216, United States
-
Open Door Health
Providence, Rhode Island, 02907, United States
-
University of Mississippi Medical Center
Jackson, Mississippi, 39216, United States
-
Wake Forest Baptist Health
Greensboro, North Carolina, 27405, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Five-Minute Finger-Prick test could speed syphilis diagnosis in pregnancy
- Can a common antibiotic prevent STIs? new study tests two dosing strategies
- ER syphilis screening for pregnant women could save lives
- Could a pill replace the shot for syphilis?
- New study offers free STI care to black youth in the deep south
- Free sexual health Check-Ups: will they satisfy young people?